David A Priestman

David A Priestman

University of Oxford

H-index: 28

Europe-United Kingdom

About David A Priestman

David A Priestman, With an exceptional h-index of 28 and a recent h-index of 19 (since 2020), a distinguished researcher at University of Oxford,

His recent articles reflect a diverse array of research interests and contributions to the field:

Analysis of glycosphingolipids from cell lines

Analysis of glycosphingolipids from animal tissues

Compartmentalisation proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation

A mouse systems genetics approach reveals common and uncommon genetic modifiers of hepatic lysosomal enzyme activities and glycosphingolipids

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment

Analysis of glycosphingolipids from human cerebrospinal fluid

Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients

Glycosphingolipid changes in plasma in Parkinson's disease independent of glucosylceramide levels

David A Priestman Information

University

Position

___

Citations(all)

3542

Citations(since 2020)

1380

Cited By

2879

hIndex(all)

28

hIndex(since 2020)

19

i10Index(all)

52

i10Index(since 2020)

28

Email

University Profile Page

Google Scholar

Top articles of David A Priestman

Analysis of glycosphingolipids from cell lines

2024/2/9

David A Priestman
David A Priestman

H-Index: 17

Analysis of glycosphingolipids from animal tissues

2024/2/9

David A Priestman
David A Priestman

H-Index: 17

Compartmentalisation proteomics revealed endolysosomal protein network changes in a goat model of atrial fibrillation

iScience

2023/3/12

A mouse systems genetics approach reveals common and uncommon genetic modifiers of hepatic lysosomal enzyme activities and glycosphingolipids

International Journal of Molecular Sciences

2023/3/3

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment

Cancer Immunology, Immunotherapy

2023/3

Analysis of glycosphingolipids from human cerebrospinal fluid

2023/2/20

David A Priestman
David A Priestman

H-Index: 17

Glb1 knockout mouse model shares natural history with type II GM1 gangliosidosis patients

Molecular genetics and metabolism

2023/2/1

Glycosphingolipid changes in plasma in Parkinson's disease independent of glucosylceramide levels

Movement Disorders

2022/10

Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT

Journal of Experimental Medicine

2022/6/15

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease

2022/2

David A Priestman
David A Priestman

H-Index: 17

Identification of genetic modifiers of murine hepatic β-glucocerebrosidase activity

Biochemistry and Biophysics Reports

2021/12/1

A modified density gradient proteomic-based method to analyze endolysosomal proteins in cardiac tissue

Iscience

2021/9/24

Correction: Molecular basis for a new bovine model of Niemann-Pick type C disease

Plos one

2021/8/31

David A Priestman
David A Priestman

H-Index: 17

Oral Glucosamine Ameliorates Aggravated Neurological Phenotype in Mucopolysaccharidosis III Type C Mouse Model Expressing Misfolded HGSNAT Variant

bioRxiv

2021/8/27

An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions

Cell Reports Medicine

2021/7/20

Cardiac Atrial Compartmentalisation Proteomics: A Modified Density Gradient Method to Analyse Endo-lysosomal Proteins

bioRxiv

2021/2/22

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

Molecular Neurodegeneration

2020/12

David A Priestman
David A Priestman

H-Index: 17

Molecular basis for a new bovine model of Niemann-Pick type C disease

Plos one

2020/9/24

David A Priestman
David A Priestman

H-Index: 17

Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes

Human Molecular Genetics

2020/1/10

Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms

Journal of clinical medicine

2020/2/1

David A Priestman
David A Priestman

H-Index: 17

Shaukat Khan
Shaukat Khan

H-Index: 23

See List of Professors in David A Priestman University(University of Oxford)

Co-Authors

academic-engine